Paper136605
Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection.
Storb R and 2 others. N Engl J Med, 1977. Cited by 346 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. Papers, record 136605. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/136605
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection.
- PubMed
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anemia, Aplastic | Major topic |
| Bone Marrow Cells | Major topic |
| Bone Marrow Transplantation | Major topic |
| Graft Rejection | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Bone Marrow | |
| Cell Count | |
| Child | |
| Child, Preschool | |
| Female | |
| HLA Antigens | |
| Humans | |
| Immunosuppressive Agents | |
| Lymphocyte Culture Test, Mixed | |
| Male | |
| Middle Aged | |
| Probability | |
| Prognosis | |
| Regression Analysis | |
| Remission, Spontaneous | |
| Transplantation Immunology | |
| Transplantation, Homologous |
Source PubMed
Cited by57
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 346 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,637,641 | Allogeneic hematopoietic cell transplantation for aplastic anemia: a single institution experience across 6 decades. | Blood Adv | 2026 | https://conductscience.org/library/papers/41637641 | PubMed |
| 38,884,110 | Single-cell genomics-based immune and disease monitoring in blood malignancies. | Clin Hematol Int | 2024 | https://conductscience.org/library/papers/38884110 | PubMed |
| 34,214,736 | Fractionated Infusion of Hematopoietic Progenitor Cells Does Not Improve Neutrophil Recovery or Survival in Allograft Recipients. | Transplant Cell Ther | 2021 | https://conductscience.org/library/papers/34214736 | PubMed |
| 34,128,593 | Incidence, Management, and Prognosis of Graft Failure and Autologous Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation. | J Korean Med Sci | 2021 | https://conductscience.org/library/papers/34128593 | PubMed |
| 33,054,108 | History of hematopoietic cell transplantation: challenges and progress. | Haematologica | 2020 | https://conductscience.org/library/papers/33054108 | PubMed |
| 31,258,425 | Curative Therapies for Sickle Cell Disease. | Ochsner J | 2019 | https://conductscience.org/library/papers/31258425 | PubMed |
| 30,108,110 | Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment. | Blood Adv | 2018 | https://conductscience.org/library/papers/30108110 | PubMed |
| 29,359,261 | Transplantation in patients with iron overload: is there a place for magnetic resonance imaging? : Transplantation in iron overload. | Heart Fail Rev | 2018 | https://conductscience.org/library/papers/29359261 | PubMed |
| 28,900,606 | Lymphocyte recovery is an independent predictor of relapse in allogeneic hematopoietic cell transplantation recipients for acute leukemia. | World J Transplant | 2017 | https://conductscience.org/library/papers/28900606 | PubMed |
| 27,479,689 | Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD? | Bone Marrow Transplant | 2016 | https://conductscience.org/library/papers/27479689 | PubMed |
| 27,088,376 | Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis. | Bone Marrow Transplant | 2016 | https://conductscience.org/library/papers/27088376 | PubMed |
| 26,797,402 | Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions. | Biol Blood Marrow Transplant | 2016 | https://conductscience.org/library/papers/26797402 | PubMed |
| 25,772,027 | Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. | Leukemia | 2015 | https://conductscience.org/library/papers/25772027 | PubMed |
| 23,222,384 | Graft failure in the modern era of allogeneic hematopoietic SCT. | Bone Marrow Transplant | 2013 | https://conductscience.org/library/papers/23222384 | PubMed |
| 23,049,292 | Busulfan and melphalan as conditioning regimen for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia in first complete remission. | Rev Bras Hematol Hemoter | 2011 | https://conductscience.org/library/papers/23049292 | PubMed |
| 22,533,862 | Success of allogeneic marrow transplantation for children with severe aplastic anaemia. | Br J Haematol | 2012 | https://conductscience.org/library/papers/22533862 | PubMed |
| 22,180,425 | Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning. | Haematologica | 2012 | https://conductscience.org/library/papers/22180425 | PubMed |
| 21,897,398 | Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation. | Bone Marrow Transplant | 2011 | https://conductscience.org/library/papers/21897398 | PubMed |
| 21,892,603 | Immunosuppressive properties of mesenchymal stem cells. | Stem Cell Rev Rep | 2012 | https://conductscience.org/library/papers/21892603 | PubMed |
| 21,804,612 | Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation. | Bone Marrow Transplant | 2012 | https://conductscience.org/library/papers/21804612 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/136605
GET https://conductscience.org/api/papers/v1/136605/cited_by?page=2